These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 30852396
1. Diagnostic and analytical performance of the hepatitis B core related antigen immunoassay in hepatitis B patients. van Halewijn GJ, Geurtsvankessel CH, Klaasse J, van Oord GW, de Knegt RJ, van Campenhout MJ, Boonstra A, van der Eijk AA. J Clin Virol; 2019 May; 114():1-5. PubMed ID: 30852396 [Abstract] [Full Text] [Related]
2. Hepatitis B core-related antigen (HBcrAg) levels in the natural history of hepatitis B virus infection in a large European cohort predominantly infected with genotypes A and D. Maasoumy B, Wiegand SB, Jaroszewicz J, Bremer B, Lehmann P, Deterding K, Taranta A, Manns MP, Wedemeyer H, Glebe D, Cornberg M. Clin Microbiol Infect; 2015 Jun; 21(6):606.e1-10. PubMed ID: 25700889 [Abstract] [Full Text] [Related]
3. Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load. Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, Maki N. J Clin Microbiol; 2002 Feb; 40(2):439-45. PubMed ID: 11825954 [Abstract] [Full Text] [Related]
4. Predictive Value of Hepatitis B Core-Related Antigen (HBcrAg) During the Natural History of Hepatitis B Virus Infection. Gou Y, Zhao Y, Rao C, Feng S, Wang T, Li D, Tao C. Clin Lab; 2017 Jul 01; 63(7):1063-1070. PubMed ID: 28792701 [Abstract] [Full Text] [Related]
5. Monitoring of serum HBV RNA, HBcrAg, HBsAg and anti-HBc levels in patients during long-term nucleoside/nucleotide analogue therapy. Liao H, Liu Y, Li X, Wang J, Chen X, Zou J, Li Q, Liu L, Wang J, Huang B, Lu F, Xu D. Antivir Ther; 2019 Jul 01; 24(2):105-115. PubMed ID: 30511941 [Abstract] [Full Text] [Related]
6. Performance evaluation of LUMIPULSE G1200 autoimmunoanalyzer for the detection of serum hepatitis B virus markers. Choi SJ, Park Y, Lee EY, Kim S, Kim HS. J Clin Lab Anal; 2013 May 01; 27(3):204-6. PubMed ID: 23440745 [Abstract] [Full Text] [Related]
8. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors. Kuhns MC, McNamara AL, Holzmayer V, Cloherty GA. Virol J; 2019 Apr 03; 16(1):43. PubMed ID: 30943997 [Abstract] [Full Text] [Related]
9. Clinical efficacy of a novel, high-sensitivity HBcrAg assay in the management of chronic hepatitis B and HBV reactivation. Inoue T, Kusumoto S, Iio E, Ogawa S, Suzuki T, Yagi S, Kaneko A, Matsuura K, Aoyagi K, Tanaka Y. J Hepatol; 2021 Aug 03; 75(2):302-310. PubMed ID: 33762167 [Abstract] [Full Text] [Related]
10. Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B. Loggi E, Vukotic R, Conti F, Grandini E, Gitto S, Cursaro C, Galli S, Furlini G, Re MC, Andreone P. J Viral Hepat; 2019 May 03; 26(5):568-575. PubMed ID: 30576048 [Abstract] [Full Text] [Related]
11. Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment. Rokuhara A, Tanaka E, Matsumoto A, Kimura T, Yamaura T, Orii K, Sun X, Yagi S, Maki N, Kiyosawa K. J Viral Hepat; 2003 Jul 03; 10(4):324-30. PubMed ID: 12823601 [Abstract] [Full Text] [Related]
12. Correlation of HBcrAg with Intrahepatic Hepatitis B Virus Total DNA and Covalently Closed Circular DNA in HBeAg-Positive Chronic Hepatitis B Patients. Wang L, Cao X, Wang Z, Gao Y, Deng J, Liu X, Zhuang H. J Clin Microbiol; 2019 Jan 03; 57(1):. PubMed ID: 30355757 [Abstract] [Full Text] [Related]
13. Correlation of HBV Core-Related Antigen with Conventional Serologic Indicators of Hepatitis B and Disease Stage. Wang Y, Jin X, Peng Q, Run H, Song Y. Clin Lab; 2024 May 01; 70(5):. PubMed ID: 38747904 [Abstract] [Full Text] [Related]
14. Analytical validation of hepatitis B core-related antigen (HBcrAg) using dried blood spots (DBS). Shimakawa Y, Vernoux L, Gabassi A, Mercier-Delarue S, Vincent JP, Simon F, Maylin S. J Viral Hepat; 2021 May 01; 28(5):837-843. PubMed ID: 33599049 [Abstract] [Full Text] [Related]
15. Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection. Caviglia GP, Olivero A, Ciancio A, Tandoi F, Troshina G, Rosso C, Abate ML, Younes R, Ribaldone DG, Smedile A, Rizzetto M, Romagnoli R, Saracco GM, Bugianesi E. Diagn Microbiol Infect Dis; 2020 Apr 01; 96(4):114985. PubMed ID: 32008810 [Abstract] [Full Text] [Related]
16. Clinical, biochemical, immunological and virological profiles of, and differential diagnosis between, patients with acute hepatitis B and chronic hepatitis B with acute flare. Han Y, Tang Q, Zhu W, Zhang X, You L. J Gastroenterol Hepatol; 2008 Nov 01; 23(11):1728-33. PubMed ID: 18823435 [Abstract] [Full Text] [Related]
17. [Fundamental and clinical evaluation of hepatitis B virus core-related antigen assay by LUMIPULSE f]. Tanaka Y, Takagi K, Hiramatsu K, Naganuma H, Iida T, Takasaka Y, Mizokami M. Rinsho Byori; 2006 Jul 01; 54(7):692-8. PubMed ID: 16913659 [Abstract] [Full Text] [Related]
18. Hepatitis B virus markers in anti-HBc only positive individuals. Weber B, Melchior W, Gehrke R, Doerr HW, Berger A, Rabenau H. J Med Virol; 2001 Jul 01; 64(3):312-9. PubMed ID: 11424120 [Abstract] [Full Text] [Related]
19. Quantitative serum HBV markers in predicting phases of natural history of chronic HBV infection. Zhang ZQ, Shi BS, Lu W, Huang D, Wang YB, Feng YL. J Virol Methods; 2021 Oct 01; 296():114226. PubMed ID: 34217779 [Abstract] [Full Text] [Related]
20. Performance evaluation of new automated hepatitis B viral markers in the clinical laboratory: two quantitative hepatitis B surface antigen assays and an HBV core-related antigen assay. Park Y, Hong DJ, Shin S, Cho Y, Kim HS. Am J Clin Pathol; 2012 May 01; 137(5):770-7. PubMed ID: 22523216 [Abstract] [Full Text] [Related] Page: [Next] [New Search]